The interaction of NGF with its high-affinity receptor TrkA mediates different cellular pathways related to Alzheimer’s disease, pain, ocular dysfunction, and cancer. This evidence concerns the gene NTRK1 and early-onset autosomal dominant Alzheimer disease.